LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 308 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.69 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $8,731,964 | -20.3% | 145,727 | -4.0% | 0.00% | 0.0% |
Q2 2023 | $10,949,721 | -1.5% | 151,869 | +0.5% | 0.00% | 0.0% |
Q1 2023 | $11,116,427 | +6.1% | 151,121 | -3.6% | 0.00% | 0.0% |
Q4 2022 | $10,476,412 | -25.1% | 156,833 | -3.5% | 0.00% | -33.3% |
Q3 2022 | $13,996,000 | -4.7% | 162,545 | -1.3% | 0.00% | 0.0% |
Q2 2022 | $14,692,000 | -29.0% | 164,662 | -10.5% | 0.00% | -25.0% |
Q1 2022 | $20,705,000 | -30.1% | 184,068 | -4.0% | 0.00% | -20.0% |
Q4 2021 | $29,605,000 | +12.7% | 191,665 | +1.6% | 0.01% | 0.0% |
Q3 2021 | $26,277,000 | +5.4% | 188,614 | -0.7% | 0.01% | 0.0% |
Q2 2021 | $24,923,000 | -9.5% | 189,976 | +5.2% | 0.01% | -16.7% |
Q1 2021 | $27,528,000 | +40.4% | 180,580 | -8.4% | 0.01% | +50.0% |
Q4 2020 | $19,601,000 | -1.5% | 197,104 | -5.5% | 0.00% | -20.0% |
Q3 2020 | $19,890,000 | -20.1% | 208,651 | -6.2% | 0.01% | -28.6% |
Q2 2020 | $24,883,000 | +46.4% | 222,464 | -4.8% | 0.01% | +16.7% |
Q1 2020 | $17,002,000 | -38.8% | 233,790 | -12.3% | 0.01% | -14.3% |
Q4 2019 | $27,802,000 | -7.2% | 266,585 | -11.4% | 0.01% | -12.5% |
Q3 2019 | $29,952,000 | -23.5% | 300,912 | -12.3% | 0.01% | -27.3% |
Q2 2019 | $39,162,000 | -9.6% | 343,072 | -0.5% | 0.01% | -8.3% |
Q1 2019 | $43,342,000 | -21.6% | 344,776 | -15.4% | 0.01% | -29.4% |
Q4 2018 | $55,275,000 | -59.6% | 407,336 | -18.2% | 0.02% | -51.4% |
Q3 2018 | $136,758,000 | +28.2% | 498,228 | -3.2% | 0.04% | +20.7% |
Q2 2018 | $106,647,000 | +24.3% | 514,777 | -0.9% | 0.03% | +20.8% |
Q1 2018 | $85,795,000 | +19.0% | 519,465 | -1.3% | 0.02% | +26.3% |
Q4 2017 | $72,081,000 | +0.6% | 526,411 | -0.0% | 0.02% | -5.0% |
Q3 2017 | $71,683,000 | +5.4% | 526,499 | -6.0% | 0.02% | +5.3% |
Q2 2017 | $68,005,000 | +16.2% | 560,181 | +1.3% | 0.02% | +18.8% |
Q1 2017 | $58,522,000 | +7.9% | 552,936 | +3.6% | 0.02% | 0.0% |
Q4 2016 | $54,226,000 | +9.4% | 533,670 | +9.9% | 0.02% | +6.7% |
Q3 2016 | $49,561,000 | -15.1% | 485,614 | -0.7% | 0.02% | -16.7% |
Q2 2016 | $58,344,000 | -7.6% | 489,176 | -17.1% | 0.02% | -5.3% |
Q1 2016 | $63,163,000 | +7.1% | 589,823 | +8.4% | 0.02% | +5.6% |
Q4 2015 | $58,986,000 | +12.6% | 544,054 | -11.1% | 0.02% | +12.5% |
Q3 2015 | $52,405,000 | -14.5% | 611,853 | +0.7% | 0.02% | -5.9% |
Q2 2015 | $61,285,000 | +108.1% | 607,384 | +59.0% | 0.02% | +112.5% |
Q1 2015 | $29,449,000 | +164.5% | 381,890 | +82.5% | 0.01% | +166.7% |
Q4 2014 | $11,135,000 | +11.1% | 209,252 | -1.9% | 0.00% | 0.0% |
Q3 2014 | $10,027,000 | -60.6% | 213,399 | -47.8% | 0.00% | 0.0% |
Q2 2014 | $25,476,000 | +91.4% | 408,968 | +106.7% | 0.00% | -25.0% |
Q1 2014 | $13,309,000 | +32.3% | 197,842 | +3.5% | 0.00% | +33.3% |
Q4 2013 | $10,056,000 | +20.3% | 191,169 | -1.1% | 0.00% | +200.0% |
Q3 2013 | $8,362,000 | +103.5% | 193,202 | +75.8% | 0.00% | 0.0% |
Q2 2013 | $4,110,000 | – | 109,895 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
KNOTT DAVID M | 1,249,766 | $58,726,504,000 | 11.17% |
BVF INC/IL | 1,108,763 | $52,101,000 | 10.82% |
GROW Partners, LLC | 132,500 | $6,226,000 | 5.58% |
CARDINAL CAPITAL MANAGEMENT LLC /CT | 936,825 | $44,021,000 | 2.73% |
First Light Asset Management, LLC | 76,366 | $3,588,000 | 2.45% |
Healthcare Value Capital, LLC | 50,000 | $2,350,000 | 2.27% |
OBERWEIS ASSET MANAGEMENT INC/ | 168,337 | $7,910,000 | 2.17% |
RK Capital | 174,283 | $8,190,000 | 1.67% |
Nichols Asset Management LLC | 133,368 | $6,267,000 | 1.30% |
ASHFORD CAPITAL MANAGEMENT INC | 108,289 | $5,089,000 | 1.09% |